Allogene Therapeutics, Inc. ALLO
Set alert
1.18 USD -0.07 -5.60%
At close · Oct 30
1.20 +0.02 +1.69%
After hours · Oct 30, 7:44 PM ET
1.16 Day range 1.26
1.05 52-week range 3.06
- YTD
- -13.87%
- 1 year
- -2.48%
- Open
- 1.24
- Prev close
- 1.25
- Mkt cap
- 407.68M
- Vol
- 9.76M
- Avg vol
- 5.88M
- EPS
- -0.66
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.16
- High
- 1.26
- Forward P/E
- -1.50
- Beta
- 0.84
- Short ratio
- 11.46
- Inst. own
- 80.20%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 2.47
- 200-d avg
- 2.83
- 1y target
- 9.04
5D chart
Signals (52)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 12:55 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:55 PM | 1 day ago |
| RSI: Oversold | Oct 30, 11:50 AM | 1 day ago |
| RSI: Oversold | Oct 30, 11:00 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 10:40 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:40 AM | 1 day ago |
| RSI: Oversold | Oct 30, 9:40 AM | 1 day ago |
| MACD: Buy Signal | Oct 29, 3:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:40 PM | 2 days ago |
| RSI: Oversold | Oct 29, 3:20 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:45 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 2:20 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 2:00 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 1:45 PM | 2 days ago |
| RSI: Oversold | Oct 29, 1:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:15 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:15 PM | 3 days ago |
| RSI: Oversold | Oct 28, 1:40 PM | 3 days ago |
| RSI: Oversold | Oct 28, 1:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:50 AM | 3 days ago |
| RSI: Overbought | Oct 28, 11:10 AM | 3 days ago |
| RSI: Overbought | Oct 28, 10:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 9:55 AM | 3 days ago |
| SMA: Bearish | Oct 27, 3:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 3:30 PM | 4 days ago |
| RSI: Overbought | Oct 27, 2:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 2:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:35 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 12:15 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 10:15 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 10:10 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 10:05 AM | 4 days ago |
| MACD: Sell Signal | Oct 27, 10:00 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:50 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:35 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:35 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 26, 3:25 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 12:45 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 12:40 PM | 5 days ago |
| SMA: Bullish | Oct 26, 10:35 AM | 5 days ago |
Financial health
Altman Z-Score
-3.49 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -1.6×
FY 2017 5y median -1.6× FY 2025
P/S 0.0×
FY 2017 5y median 5303× FY 2025
P/B 1.0×
FY 2017 5y median 1.0× FY 2025
P/FCF -2.0×
FY 2017 5y median -2.1× FY 2025
EV/EBITDA -1.9×
FY 2017 5y median -1.9× FY 2025
EV/Sales 0.0×
FY 2017 5y median 5429× FY 2025
FCF Yield -49.5%
FY 2017 5y median -47.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2017 5y median -215087.2% FY 2025
Net Margin 0.0%
FY 2017 5y median -218214.1% FY 2025
ROE -65.3%
FY 2017 5y median -61.0% FY 2025
ROIC -52.8%
FY 2017 5y median -52.5% FY 2025
ROA -45.9%
FY 2017 5y median -45.9% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2017 FY 2025
Operating Income 24.3%
FY 2017 FY 2025
EPS (diluted) 34.1%
FY 2017 FY 2025
Free Cash Flow 25.6%
FY 2017 FY 2025
Financial Health
Current Ratio 7.9×
FY 2017 5y median 9.8× FY 2025
Quick Ratio 7.9×
FY 2017 5y median 9.8× FY 2025
Debt / Equity 0.3×
FY 2017 5y median 0.2× FY 2025
Net Debt / EBITDA -0.2×
FY 2017 5y median -0.1× FY 2025
Interest Coverage -192×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31